GETWAB

01 / Contract Profile

75A50119F33009 Federal Contract Award

Agency code 7505

EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL MODIFICATION TO DESCOPE WORK AND DEOBLIGATE FUNDS.

02 / Contract Size and Status

What is the recorded size and timing of this contract?

Net obligations$25.37M
Contract actions37
Potential value-$104.1K
Latest actionSep 30, 2025
Effective dateSep 20, 2019
Completion dateMar 31, 2025
NAICS markets6
PSC categories4

03 / Spending Trend

75A50119F33009 contract spending by fiscal year

Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.

Latest fiscal year obligations-$104.1K
FY 2025
Net obligationsComplete recorded range
Fiscal yearNet obligationsActionsChange
FY 2019$20.29M11
FY 2020$2.62M4−87.1%
FY 2021$2.33M3−10.9%
FY 2022$236.8K3−89.8%
FY 2023$08−100.0%
FY 2024$06
FY 2025-$104.1K2

04 / Federal Buyer

Which organization manages this contract?

05 / Contractor

Who holds this federal contract?

BATTELLE MEMORIAL INSTITUTE

UEI F125YU6SWK59 · CAGE 79986

06 / NAICS Industries

Which industries classify this contract?

CodeDescriptionObligationsActionsShare
325414BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$18.16M1071.6%
541711RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY$6.85M1727.0%
541611ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES$257.4K61.0%
339113SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING$56.7K10.2%
339112SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING$33.6K20.1%
541618OTHER MANAGEMENT CONSULTING SERVICES$11.5K10.0%

07 / Products and Services

What products or services were purchased?

CodeDescriptionObligationsActionsShare
6505DRUGS AND BIOLOGICALS$18.25M1372.0%
AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT$6.85M1727.0%
R429SUPPORT- PROFESSIONAL: EMERGENCY RESPONSE/DISASTER PLANNING/PREPAREDNESS SUPPORT$257.4K61.0%
D317IT AND TELECOM- WEB-BASED SUBSCRIPTION$11.5K10.0%

08 / Place of Performance

Where is the work recorded?

COLUMBUS, FRANKLIN, OHIO, UNITED STATES

ZIP 432012696

09 / Contract Actions

What modifications and obligations were recorded?

Signed dateModificationObligationContracting officeNAICSPSC
Sep 30, 2025P00016-$104.1KBARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501541711AN13
Sep 9, 2025P00009-$1BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A5013254146505
Oct 9, 2024P00015$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501541711AN13
Sep 16, 2024P00014$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501541711AN13
Sep 10, 2024P00013$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501541711AN13
May 7, 2024P00012$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501541711AN13
Feb 28, 2024P00008$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A5013254146505
Feb 27, 2024P00011$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501541711AN13
Dec 15, 2023P00010$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501541711AN13
Nov 21, 2023P00007$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A5013254146505
Aug 9, 2023P00009$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501541711AN13
Jul 12, 2023P00006$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A5013254146505
Jul 3, 2023P00005$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A5013254146505
Feb 23, 2023P00004$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A5013254146505
Feb 16, 2023P00008$0BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501541711AN13

10 / Reading the Contract

How should this award record be interpreted?

Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.

01

Verify the buyer

Agency and office identify who manages the procurement relationship.

02

Follow modifications

Each action can change funding, scope, dates, or administrative terms.

03

Compare the market

Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.